Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Salarius Pharmaceuticals (SLRX) Insider Trading & Ownership

Salarius Pharmaceuticals logo

Salarius Pharmaceuticals (NASDAQ:SLRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.30%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$19.75K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$17.28
Get SLRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Salarius Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLRX Insider Buying and Selling by Quarter

Salarius Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/30/2025
Arnold C Hanish
Director
Sell12$0.64$7.68  
12/30/2025
Arnold C Hanish
Director
Sell15$0.64$9.60  
11/20/2025
Arnold C Hanish
Director
Buy5,000$0.75$3,750.00  
11/20/2025
Mark J Rosenblum
CFO
Buy20,000$0.80$16,000.00  
(Data available from 1/1/2013 forward)

SLRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Salarius Pharmaceuticals includes Arnold C Hanish, and Mark J Rosenblum. Learn more on insiders at SLRX.

0.30% of Salarius Pharmaceuticals stock is owned by insiders. Learn more on SLRX's insider holdings.

The following insiders have purchased SLRX shares in the last 24 months: Arnold C Hanish ($3,750.00), and Mark J Rosenblum ($16,000.00).

Insiders have purchased a total of 25,000 SLRX shares in the last 24 months for a total of $19,750.00 bought.

The following insider sold SLRX shares in the last 24 months: Arnold C Hanish ($17.28).

Insiders have sold a total of 27 Salarius Pharmaceuticals shares in the last 24 months for a total of $17.28 sold.



This page (NASDAQ:SLRX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners